Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Neuroderm Ltd (NDRM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Neuroderm Ltd's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Neuroderm Ltd historical data, for real-time data please try another search
38.85 0.00    0.00%
17/10 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 38.85 - 38.95
Type:  Equity
Market:  United States
Neuroderm Ltd 38.85 0.00 0.00%

Neuroderm Ltd Company Profile

 
Read the Neuroderm Ltd company profile to learn more about the business and the management team. View Neuroderm Ltd facts about employee data, company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

55

Equity Type

ORD

Neuroderm Ltd., a clinical-stage pharmaceutical company that develops and manufactures pharmaceutical products for the treatment of central nervous system (CNS) disorders. The company develop a liquid formulation of levodopa/carbidopa (LD/CD) that increases dopamine concentrations in the brain, improves nerve conduction, and alleviates movement disorders related to Parkinson’s disease. It also develops ND0701, a subcutaneously delivered apomorphine formulation for patients who suffer from moderate to severe Parkinson’s disease. The company provides clinical trial for the treatment of cognition disorders associated with CNS diseases, such as ADD/ADHD, Alzheimer’s disease, and schizophrenia. Neuroderm Ltd. was founded in 2003 and is based in Rehovot, Israel. As of October 18, 2017, Neuroderm Ltd. operates as a subsidiary of Mitsubishi Tanabe Pharma Corporation.

Contact Information

Address 3 Pekeris Street Ruhrberg Science Building
Bell Entrance Rabin Science Park Rehovot, 7670212
Israel
Phone 972 8 946 2729
Fax 972 8 946 1729
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NDRM Price Commentary

Write your thoughts about Neuroderm Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email